G. Idéo
About
In The Last Decade
G. Idéo
22 papers receiving 307 citations
Peers
Comparison fields: 5 of 69
- Hepatology 120
- Epidemiology 111
- Pharmacology 83
- Rheumatology 41
- Molecular Biology 37
Countries citing papers authored by G. Idéo
This map shows the geographic impact of G. Idéo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Idéo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Idéo more than expected).
Fields of papers citing papers by G. Idéo
This network shows the impact of papers produced by G. Idéo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Idéo. The network helps show where G. Idéo may publish in the future.
Co-authorship network of co-authors of G. Idéo
This figure shows the co-authorship network connecting the top 25 collaborators of G. Idéo. A scholar is included among the top collaborators of G. Idéo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Idéo. G. Idéo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant. | 14 |
| 5 | Cyanocobalamin absorption abnormality in alcoholics is improved by oral supplementation with a fermented papaya-derived antioxidant. | 3 |
| 6 | 4 | |
| 7 | 6 | |
| 8 | 5 | |
| 9 | 51 | |
| 10 | Intramuscular beta interferon for chronic hepatitis C: is it worth trying? | 7 |
| 11 | Abstinence-induced oxidative stress in moderate drinkers is improved by bionormalizer. | 19 |
| 12 | Serum cholesterol and chronic hepatitis C. | 46 |
| 13 | Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment. | 8 |
| 14 | Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up. | 4 |
| 15 | 8 | |
| 16 | Alpha interferon treatment in chronic hepatitis C. | 9 |
| 17 | Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970's and the 1980's. The Italian RIFLE Pooling Project. Risk factors and life expectancy. | 24 |
| 18 | Factors in the development of a liver transplantation programme: experience of 100 consecutive transplantations in Milan's Niguarda Hospital. | 1 |
| 19 | 25 | |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.